AbbVie Inc
(NEOE:ABBV)
C$
25.92
0.11 (0.43%)
Market Cap: 457.28 Bil
Enterprise Value: 549.05 Bil
PE Ratio: 62.77
PB Ratio: 52.94
GF Score: 73/100 Abbvie Inc at JPMorgan Healthcare Conference Transcript
Jan 10, 2023 / 11:00PM GMT
Release Date Price:
C$23.71
(-1.17%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing AbbVie today. From the company, we have a presentation from Rick Gonzalez, AbbVie's Chairman and CEO. And after the presentation, we're going to have a Q&A session with a broader swath of the management team, including Rob Michael, President of AbbVie; Chief Commercial Officer, Jeff Stewart; and Chief Medical Officer, Roopal Thakkar.
So with that, I'm going to turn it over to Rick. Happy New Year, and thanks for joining us today.
Richard A. Gonzalez
AbbVie Inc. - Chairman & CEO
All right. Thanks, Chris.
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Thank you.
Richard A. Gonzalez
AbbVie Inc. - Chairman & CEO
Well, thank you, Chris, and good afternoon, everyone. It's certainly a pleasure to be here with all of you. Before I begin
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot